Breaking News, Collaborations & Alliances

UQ, CEPI and CSL Partner on Development and Manufacture of COVID-19 Vax Candidate

CSL appointed manufacturer for University of Queensland's "molecular clamp" enabled COVID-19 vaccine candidate

By: Contract Pharma

Contract Pharma Staff

CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have entered into a new agreement to accelerate the development, manufacture and distribution of a COVID-19 vaccine candidate which has been pioneered by researchers at UQ. The agreement formalizes the support provided by CSL to UQ and CEPI from the outset of the pandemic earlier this year.   CEPI and CSL will fund the development and manufacture of UQ’s “molecular clamp” enable...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters